The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism
Molecular Pharmacology (2006) - Comments
pubmed: 16672643  doi: 10.1124/mol.106.024505  issn: 0026-895x 

Ning Gao, Lora Kramer, Mohamed Rahmani, Paul Dent, Steven Grant